OBJECTIVES

To undertake a qualitative evaluation of the implementation of the Penile and Testicular cancer multidisciplinary meeting (PEN-TEST MDM) model pilot including the acceptability, adoption, appropriateness, feasibility, and requirements for sustaining the model from the perspectives of key informants.

DESIGN, SETTING, PARTICIPANTS: A qualitative evaluation of the PEN-TEST MDM model six-month implementation pilot at Barwon Health (Victoria, Australia) (January to July 2024) was undertaken from July to September 2024. Qualitative data was obtained from semi-structured interviews undertaken with key informants, including working group members and end-users (referring and attending clinicians). Data was analysed abductively and reported, guided by Proctor’s implementation outcomes framework.

MAIN OUTCOME MEASURES

Key themes pertaining to implementation outcomes based on qualitative analysis.

RESULTS

Thirteen key informants were interviewed. Three key concepts were developed: (1) value for the clinician workforce: acceptability and adoption, (2) optimising patient care: appropriateness and feasibility, and (3) considerations for sustainability and scalability.

CONCLUSIONS

The PEN-TEST MDM model is a promising approach for reviewing patient cases with penile or testicular cancer. Findings support the importance of ongoing stakeholder engagement to shape the next iteration, and further investment to refine, sustain, and scale the model. Subject to this, scoping opportunities for scaling to other less common or rare cancers is warranted. The MDM model established has potential to be transformative in addressing inequitable access to specialist cancer care.

SUPPLEMENTARY INFORMATION

The online version contains supplementary material available at 10.1186/s12913-025-12990-5.